日本精品在线一区,天堂久久一区二区,国产精品久久久久久久久久不蜜月,午夜久久久久久久久久一区二区,久久免费99精品久久久久久,久久久久久1,久久久久久久久久网站

    《2011ESC心肌血管重建指南》內(nèi)容簡(jiǎn)介：

    Guidelines and Expert Consensus Documents summarize andevaluate all available evidence with the aim of assisting physiciansin selecting the best management strategy for an individualpatient suffering from a given condition, taking into account theimpact on outcome and the risk – benefit ratio of diagnostic ortherapeutic means. Guidelines are no substitutes for textbooksand their legal implications have been discussed previously. Guide-lines and recommendations should help physicians to makedecisions in their daily practice. However, the ultimate judgementregarding the care of an individual patient must be made by his/herresponsible physician（s）.

    《2011ESC心肌血管重建指南》內(nèi)容預(yù)覽：

    The recommendations for formulating and issuing ESC Guide-lines and Expert Consensus Documents can be found on theESC website （http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx）。

    Members of this Task Force were selected by the European Societyof Cardiology （ESC） and the European Association forCardio-Thoracic Surgery （EACTS） to represent all physicians involvedwith the medical and surgical care of patients with coronary arterydisease （CAD）。 A critical evaluation of diagnostic and therapeutic pro-cedures is performed including assessment of the risk–benefit ratio.Estimates of expected health outcomes for society are included,where data exist. The level of evidence and the strength of recommen-dation of particular treatment options are weighed and graded accord-ing to predefined scales, as outlined in Tables 1 and 2.

    The members of the Task Force have provided disclosure state-ments of all relationships that might be perceived as real or poten-tial sources of conflicts of interest. These disclosure forms are kepton file at European Heart House, headquarters of the ESC. Anychanges in conflict of interest that arose during the writingperiod were notified to the ESC. The Task Force report receivedits entire financial support from the ESC and EACTS, without anyinvolvement of the pharmaceutical, device, or surgical industry.

    點(diǎn)擊下載***：《2011ESC心肌血管重建指南》